Nanjing Vazyme Biotech Co., Ltd. (688105.SS) SHH

13.92

-4.86(-25.88%)

Updated at June 03 10:50AM

Currency In CNY

Valuation

Market Cap8.49B
Enterprise Value8.5B
P/E Ratio-534.28
PEG Ratio11.47
Price/Sales Ratio5.28
Price/Book Ratio2.07
Enterprise/Revenue5.33
Enterprise/EBITDA232.23

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.01
Operating Margin-0.03

Management Effectiveness

Return On Assets-0
Return On Equity-0

Income Statement

Revenue1.38B
Revenue/Share3.38
Gross Profit-40.48M
EBITDA56.88M
Net Income-16.97M
Diluted EPS-0.04

Balance Sheet

Total Cash2.94B
Total Cash/Share7.03
Total Debt972M
Total Debt/Equity0.26
Current Ratio3.39
Book Value Per Share9.07

Price History

52-Week Change-18.38
52-Week High26.77
52-Week Low18.17
Moving Average 50 Days19.76
Moving Average 200 Days21.33

Statistics

Average Volume1.96M
Shares Outstanding397.73M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.15
Trailing Annual Dividend Yield0.8
Payout Ratio-5.13
Last Split FactorN/A
Last Split DateN/A